Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2013-03-26 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Convocation - NL.pdf
AGM Information Classification · 100% confidence The document explicitly invites shareholders to the 'jaarlijkse Algemene Vergadering' (Annual General Meeting or AGM) on April 25, 2013. The agenda items cover standard AGM topics such as approving annual results (for the year ended December 31, 2012), approving the remuneration report, granting discharge to directors, reappointing directors, and voting on specific capital/financing proposals (share grants, stock purchase plans, and change of control provisions related to debt instruments). The structure, content, and explicit mention of the 'Algemene Vergadering' confirm this is material related to the AGM. Therefore, the appropriate classification is AGM-R (AGM Information).
2013-03-26 Dutch
Acquisition of own shares_ENG (14-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition of own shares" and details transactions where UCB SA/NV sold options and subsequently purchased UCB shares, both from a counterparty and on the open market. The text explicitly mentions the acquisition and distribution of shares related to stock award plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate classification is Transaction in Own Shares (POS). The document length (4603 chars) is substantial enough that it is not merely an announcement of a report (RPA/RNS), but the report itself detailing the transaction.
2013-03-14 English
Acquisition of own shares_FR (14-03).pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Acquisition d'actions propres" (Acquisition of own shares) and the text details transactions where UCB SA acquired shares (120,000 shares via a counterparty bank and 1,614 shares on the open market) and discusses the resulting total share count. This activity directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a regulatory announcement detailing these specific transactions, not a general regulatory filing (RNS) or a report announcement (RPA).
2013-03-14 French
Acquisition of own shares_NL (14-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Aankoop van eigen aandelen" (Purchase of own shares) and details specific transactions where UCB NV bought back its own shares on the stock exchange and through a discretionary mandate involving options. This activity directly corresponds to the definition of a company reporting transactions involving its own stock. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification for this content, as it explicitly details share repurchases/acquisitions.
2013-03-14 Dutch
Acquisition of own shares_ENG (11-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition of own shares" and details a transaction where UCB SA/NV sold share options and subsequently purchased 140,000 UCB shares from a counterparty. It explicitly states the number of shares owned after the transaction and the percentage of total issued shares. This activity directly relates to the company buying back or selling its own shares (share repurchase/issuance). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement, not a comprehensive annual or interim report, nor is it a general regulatory filing fallback.
2013-03-11 English
Acquisition of own shares_FR (11-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details a transaction where UCB SA sold options and subsequently acquired 140,000 UCB shares from a counterparty bank. This action directly relates to the company managing its own stock, which falls under the definition of a share repurchase or transaction in own shares. The filing type code corresponding to this activity is POS (Transaction in Own Shares). The document is a direct announcement of the transaction, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2013-03-11 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.